FDA Drug Recalls

Recalls / Class II

Class IID-0134-2021

Product

IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Affected lot / code info
Lot # 1029202005,Exp 11/29/2020; Lot #1102202014, Exp 12/08/2020; Lot #1112202002, Exp 12/12/2020

Why it was recalled

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Recalling firm

Firm
Advanced Nutriceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
836 E 86th St, N/A, Indianapolis, Indiana 46240-1806

Distribution

Quantity
3 vials
Distribution pattern
CA, CO, FL, IN, KY, OH, TX

Timeline

Recall initiated
2020-11-30
FDA classified
2020-12-11
Posted by FDA
2020-12-23
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0134-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls